M. Scot Roberts
2022
In 2022, M. Scot Roberts earned a total compensation of $1.4M as Chief Scientific Officer at PharmAthene, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,000 |
|---|---|
| Option Awards | $572,395 |
| Salary | $425,000 |
| Stock Awards | $234,183 |
| Other | $4,255 |
| Total | $1,405,833 |
Roberts received $572.4K in option awards, accounting for 41% of the total pay in 2022.
Roberts also received $170K in non-equity incentive plan, $425K in salary, $234.2K in stock awards and $4.3K in other compensation.
Rankings
In 2022, M. Scot Roberts' compensation ranked 2,368th out of 5,760 executives tracked by ExecPay. In other words, Roberts earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,368 out of 5,760 | 59th |
Division Manufacturing | 1,297 out of 3,136 | 59th |
Major group Chemicals And Allied Products | 577 out of 1,422 | 59th |
Industry group Drugs | 532 out of 1,323 | 60th |
Industry Pharmaceutical Preparations | 384 out of 969 | 60th |
Source: SEC filing on August 16, 2023.
Roberts' colleagues
We found three more compensation records of executives who worked with M. Scot Roberts at PharmAthene in 2022.